Specialized Research Khavinson Bioregulator

Vesugen

Also known as: Peptídeo vascular

Molecular Identifiers

Molecular Formula

C15H26N4O8

PubChem CID

87571363

Molecular Weight

390.39 Da

Overview

Vascular bioregulatory tripeptide developed by the Khavinson group. Regulates gene expression in vascular endothelium and supports the integrity of blood vessel walls. Used in short cycles for vascular system protection and support.

Sequence (1 letter): KED
Extended notation: Lys-Glu-Asp

Half-life

~2-4 hours

Administration Route

Subcutaneous or intramuscular

Category

Specialized Research

Mechanism of Action

  • Regulation of gene expression in vascular endothelium
  • Support for vascular wall integrity and elasticity
  • Normalization of endothelial function and nitric oxide production
  • Modulation of vascular tone and microcirculation
  • Bioregulatory effect on the circulatory system

Dosage Protocol

Data compiled from the literature. This does not constitute medical advice.

Parameter Value
Dose 5-10 mg per day via subcutaneous injection
Frequency Once daily
Timing Morning or as per protocol
Duration 10-20 days, cycled 2-4 times per year

Reported Side Effects

Adverse effects described in the literature. Severity and frequency vary between individuals.

  • Injection site pain
  • Local redness (rare)

Presentations & Preparation

Vials of Vesugen found in the research market:

20 mg

Reconstitution

  • Diluent: Bacteriostatic water
  • Volume: 2 ml per vial
  • Inject the diluent slowly against the vial wall
  • Gently swirl until fully dissolved
  • Never shake

Storage

  • Lyophilized: Refrigerated 2-8°C
  • Reconstituted: Refrigerated 2-8°C (up to 30 days)
  • Protect from direct light
  • Do not freeze after reconstitution
Reconstitution Calculator

Scientific Studies

Published studies on Vesugen.

2014 · Adv Gerontol

Epigenetic aspects of peptidergic regulation of vascular endothelial cell proliferation during aging

Khavinson VKh, Tarnovskaia SI, Lin'kova NS, Guton EO, Elashkina EV
2016 · Bull Exp Biol Med

Peptide Regulation of Skin Fibroblast Functions during Their Aging In Vitro

Lin'kova NS, Drobintseva AO, Orlova OA, Kuznetsova EP, Polyakova VO, Kvetnoy IM, Khavinson VKh

Related Peptides

Aviptadil

50-150 mcg per administration (IV or subcutaneous) · 1-3 times daily per protocol

B7-33

100-500 mcg per injection (subcutaneous) · Once daily

Bronchogen

5-10 mg per day via subcutaneous injection · Once daily

Cardiogen

5-10 mg per day subcutaneously · Once daily

Chonluten

5-10 mg per day subcutaneously · Once daily

Crystagen

5-10 mg per day via subcutaneous injection · Once daily